147 related articles for article (PubMed ID: 12378880)
21. [Biochemical evaluation of the effectiveness of antiparkinson preparations containing L-DOPA].
Vartanian KZ
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1777-81. PubMed ID: 6803476
[TBL] [Abstract][Full Text] [Related]
22. Increased dopamine content in lymphocytes from high-dose L-Dopa-treated Parkinson's disease patients.
Rajda C; Dibó G; Vécsei L; Bergquist J
Neuroimmunomodulation; 2005; 12(2):81-4. PubMed ID: 15785109
[TBL] [Abstract][Full Text] [Related]
23. [Reactivity of the DOPA--dopamine--noradrenaline--adrenaline system in epileptics].
Karlov VA; Gleĭzer MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):810-5. PubMed ID: 6410626
[TBL] [Abstract][Full Text] [Related]
24. [Catecholamine metabolism in a high-altitude environment].
Davydova NA; Senkevich IuA; Belakovskiĭ MS; Samratova SV
Kosm Biol Aviakosm Med; 1985; 19(4):60-3. PubMed ID: 3932749
[TBL] [Abstract][Full Text] [Related]
25. [The excretion of adrenaline, noradrenaline and their precursors (DOPA and dopamine) in migraine patients].
Gol'dman NB; Matlina ESh; Fets AN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):199-203. PubMed ID: 5439831
[No Abstract] [Full Text] [Related]
26. [The relationship of the metabolism of biogenic amines to affective pathology in chronic alcoholism].
Skugarevskaia EI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):896-9. PubMed ID: 5364242
[No Abstract] [Full Text] [Related]
27. Development of a screening test for L-dopa and its metabolites in urine.
Routh JI; Bannow RE
Clin Chem; 1971 Sep; 17(9):872-4. PubMed ID: 5571486
[No Abstract] [Full Text] [Related]
28. [Effect of submaximal muscular exercise of short duration on urinary excretion of catecholamines, DOPA and their metabolites].
Pequignot JM; Peyrin L; Guérin JC; Flandrois R
Arch Int Physiol Biochim; 1978 Dec; 86(5):1125-31. PubMed ID: 87164
[TBL] [Abstract][Full Text] [Related]
29. [Administration of the catecholamine precursor, L-DOPA, for evaluating their in vivo biosynthesis in hypertension].
Kiseleva ZM; Parfenova EV; Erina EV; Shkhvatsabaia IK
Kardiologiia; 1979 Oct; 19(10):55-60. PubMed ID: 502171
[TBL] [Abstract][Full Text] [Related]
30. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
Sakuma N; Nagasaka N
ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
[TBL] [Abstract][Full Text] [Related]
31. Renal handling of dopa, dopamine, norepinephrine, and epinephrine in the dog.
Ball SG; Gunn IG; Douglas IH
Am J Physiol; 1982 Jan; 242(1):F56-62. PubMed ID: 6800262
[TBL] [Abstract][Full Text] [Related]
32. [Long-term l-DOPA therapy for parkinsonism and its pathochemical aspect].
Petelin LS; Vartanian KZ; Romenskaia LKh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(12):1810-3. PubMed ID: 602554
[TBL] [Abstract][Full Text] [Related]
33. Secretion of dopa in phaeochromocytoma.
Louis WJ; Doyle AE; Heath WC; Robinson MJ
Br Med J; 1972 Nov; 4(5836):325-7. PubMed ID: 4637512
[TBL] [Abstract][Full Text] [Related]
34. Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease.
Tyce GM; Ahlskog JE; Carmichael SW; Chritton SL; Stoddard SL; van Heerden JA; Yaksh TL; Kelly PJ
J Lab Clin Med; 1989 Aug; 114(2):185-92. PubMed ID: 2754305
[TBL] [Abstract][Full Text] [Related]
35. Catecholamine metabolism during oral administration of levodopa.
Hinterberger H; Andrews CJ
Arch Neurol; 1972 Mar; 26(3):245-52. PubMed ID: 5061285
[No Abstract] [Full Text] [Related]
36. [Simultaneous fluorimetric determination of noradrenaline, adrenaline, dopamine and dopa (3,4- dihydroxyphenylalanine) in the urine].
Valori C; Brunori CA; Renzini V; Porcellati C
Ann Ist Super Sanita; 1971; 7(2):414-21. PubMed ID: 5155304
[No Abstract] [Full Text] [Related]
37. [Excretion of catecholamines and DOPA in lipid metabolism disorders].
Frolova IA; Oleneva VA; Paramonova EG; Volkova IS; Sirota II
Vopr Med Khim; 1977; (6):797-803. PubMed ID: 595486
[TBL] [Abstract][Full Text] [Related]
38. [Role of catecholamines in the biochemical mechanisms of the pathogenesis of hepatocerebral dystrophy].
Barkhatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):78-84. PubMed ID: 7124230
[TBL] [Abstract][Full Text] [Related]
39. [Urinary excretion of catecholamines and sodium and potassium levels in serum and erythrocytes in patients with renal hypertension].
Midelauri BG
Kardiologiia; 1967 Jul; 7(7):66-7. PubMed ID: 5607172
[No Abstract] [Full Text] [Related]
40. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M
Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
